$2.69T
Total marketcap
$89.44B
Total volume
BTC 50.44%     ETH 16.78%
Dominance

Annexin Pharmaceuticals AB (publ) ANNX.ST Stock

0.33 SEK {{ price }} 13.402062% {{change_pct}}%
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
122.25M SEK
LOW - HIGH [24H]
0.28 - 0.34 SEK
VOLUME [24H]
1.23M SEK
{{ volume }}
P/E Ratio
0
Earnings per share
-0.22 SEK

Annexin Pharmaceuticals AB (publ) Price Chart

Annexin Pharmaceuticals AB (publ) ANNX.ST Financial and Trading Overview

Annexin Pharmaceuticals AB (publ) stock price 0.33 SEK
Previous Close 1.03 SEK
Open 1.17 SEK
Bid 0.99 SEK x 0
Ask 1.14 SEK x 0
Day's Range 1.09 - 1.17 SEK
52 Week Range 0.61 - 1.41 SEK
Volume 1.95K SEK
Avg. Volume 45.45K SEK
Market Cap 183.72M SEK
Beta (5Y Monthly) 1.528352
PE Ratio (TTM) N/A
EPS (TTM) -0.22 SEK
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 1.9 SEK

ANNX.ST Valuation Measures

Enterprise Value 147.09M SEK
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 9.153226
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.609

Trading Information

Annexin Pharmaceuticals AB (publ) Stock Price History

Beta (5Y Monthly) 1.528352
52-Week Change 6.40%
S&P500 52-Week Change 20.43%
52 Week High 1.41 SEK
52 Week Low 0.61 SEK
50-Day Moving Average 1.09 SEK
200-Day Moving Average 1.03 SEK

ANNX.ST Share Statistics

Avg. Volume (3 month) 45.45K SEK
Avg. Daily Volume (10-Days) 52.45K SEK
Shares Outstanding 161.87M
Float 98.5M
Short Ratio N/A
% Held by Insiders 45.16%
% Held by Institutions 5.06%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -76.10%
Return on Equity (ttm) -144.38%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -40750000 SEK
Net Income Avi to Common (ttm) -41381000 SEK
Diluted EPS (ttm) -0.27
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 20.45M SEK
Total Cash Per Share (mrq) 0.13 SEK
Total Debt (mrq) 0 SEK
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 5.105
Book Value Per Share (mrq) 0.124

Cash Flow Statement

Operating Cash Flow (ttm) -42663000 SEK
Levered Free Cash Flow (ttm) -27071624 SEK

Profile of Annexin Pharmaceuticals AB (publ)

Country Sweden
State N/A
City Stockholm
Address Kammakargatan 48
ZIP 111 60
Phone N/A
Website https://www.annexinpharma.com/sv
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 5

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. It develops ANXV, a human recombinant protein. The company offers Annexin A5 to protect and repair blood vessels and counteract inflammation. Annexin Pharmaceuticals AB (publ) was founded in 2014 and is based in Stockholm, Sweden.

Q&A For Annexin Pharmaceuticals AB (publ) Stock

What is a current ANNX.ST stock price?

Annexin Pharmaceuticals AB (publ) ANNX.ST stock price today per share is 0.33 SEK.

How to purchase Annexin Pharmaceuticals AB (publ) stock?

You can buy ANNX.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Annexin Pharmaceuticals AB (publ)?

The stock symbol or ticker of Annexin Pharmaceuticals AB (publ) is ANNX.ST.

Which industry does the Annexin Pharmaceuticals AB (publ) company belong to?

The Annexin Pharmaceuticals AB (publ) industry is Biotechnology.

How many shares does Annexin Pharmaceuticals AB (publ) have in circulation?

The max supply of Annexin Pharmaceuticals AB (publ) shares is 370.45M.

What is Annexin Pharmaceuticals AB (publ) Price to Earnings Ratio (PE Ratio)?

Annexin Pharmaceuticals AB (publ) PE Ratio is now.

What was Annexin Pharmaceuticals AB (publ) earnings per share over the trailing 12 months (TTM)?

Annexin Pharmaceuticals AB (publ) EPS is -0.22 SEK over the trailing 12 months.

Which sector does the Annexin Pharmaceuticals AB (publ) company belong to?

The Annexin Pharmaceuticals AB (publ) sector is Healthcare.

Annexin Pharmaceuticals AB (publ) ANNX.ST included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
First North Sweden SEK PI FNSESEKPI 1878.6 SEK 183.37 USD
+0.16
1870.08 SEK 182.54 USD 1889.76 SEK 184.46 USD
First North Sweden EUR PI FNSEEURPI 1513.01 EUR 1653.92 USD
+0.67
1510.95 EUR 1651.67 USD 1533.41 EUR 1676.23 USD
First North Health Care PI FN20PI 934.74 EUR 1021.8 USD
-1.95
933.5 EUR 1020.44 USD 953.35 EUR 1042.15 USD
First North All-Share SEK FIRSTNORTHSEK 126.34 SEK 12.33 USD
-0.9
126.23 SEK 12.32 USD 127.53 SEK 12.45 USD
First North All-Share DKK FIRSTNORTHDKK 101.04 DKK 14.82 USD
-1.33
100.96 DKK 14.8 USD 102.42 DKK 15.02 USD
First North Sweden SEK GI FNSESEKGI 2001.34 SEK 195.36 USD
-1.07
1999.37 SEK 195.16 USD 2020.41 SEK 197.22 USD
First North Sweden EUR GI FNSEEURGI 1616.97 EUR 1767.57 USD
-1.5
1615.38 EUR 1765.82 USD 1639.39 EUR 1792.08 USD
First North Health Care GI FN20GI 939.04 EUR 1026.5 USD
-1.95
937.79 EUR 1025.13 USD 957.74 EUR 1046.94 USD
First North All-Share EUR FIRSTNORTHEUR 100.98 EUR 110.38 USD
-1.33
100.89 EUR 110.29 USD 102.35 EUR 111.88 USD